Cloxacillin Sodium
Products in Health Canada’s databases that list Cloxacillin Sodium as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 12
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 1
- Products in all
- 12
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| APO CLOXI CAP 250MG (250 MG) | 00618292 | Cancelled Post Market | Apotex Inc. | |
| APO CLOXI CAP 500MG (500 MG) | 00618284 | Cancelled Post Market | Apotex Inc. | |
| APO CLOXI FOR ORAL SOLN 125MG/5ML (125 MG) | 00644633 | Cancelled Post Market | Apotex Inc. | |
| CLOXACILLIN SODIUM FOR INJECTION (2 G) | 01912410 | Cancelled Post Market | Teva Canada Limited | |
| CLOXACILLIN SODIUM FOR INJECTION (500 MG) | 01912429 | Cancelled Post Market | Teva Canada Limited | |
| CLOXACILLIN SODIUM FOR INJECTION (1 G) | 01975447 | Cancelled Post Market | Teva Canada Limited | |
| ORBENIN CAP 250MG (250 MG) | 00002046 | Cancelled Post Market | Ayerst Laboratories | |
| ORBENIN CAP 500MG (500 MG) | 00002054 | Cancelled Post Market | Ayerst Laboratories | |
| ORBENIN INJ 2000MG (2 G) | 00002186 | Cancelled Post Market | Ayerst Laboratories | |
| ORBENIN INJ 250MG (250 MG) | 00002151 | Cancelled Post Market | Ayerst Laboratories | |
| ORBENIN PWR 125MG/5ML (125 MG) | 00002445 | Cancelled Post Market | Ayerst Laboratories | |
| TEGOPEN INJ 250MG/VIAL (250 MG) | 00407593 | Cancelled Post Market | Bristol Labs Division Of Bristol-Myers Squibb |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ORBENIN QUICK RELEASE SUSPENSIONDecember 11, 1998 · NOC 6872